In summary, targeting LRG1 could affect the inflammatory component of some eye diseases in multiple ways: through direct effects on the vasculature, via modulation of leukocyte recruitment and leukocyte differentiation/number (Fig. 2). Here, LRG1 is linked to eye disorder.